65G Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - NextCell Pharma AB

Watchlist Manager

Watchlist

Price: 0.0844 EUR 4.33% Market Closed

Market Cap: €10.1m

	NextCell Pharma AB F:65G	SE
P	Pantoro Ltd F:RKN	AU
U	Universal Technical Institute Inc F:UTI	US
	Titan Cement International SA F:TCJ	BE
D	dotDigital Group PLC SWB:3DO	UK
L	Lakeland Industries Inc F:LLI	US
F	First Helium Inc F:2MC	CA

Profitability Summary

NextCell Pharma AB's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Negative Gross Margin

-187%

Negative 3Y Average Gross Margin

-174%

Declining Gross Margin

-25% > -187%

Negative Operating Margin

-378%

Negative 3Y Average Operating Margin

-383%

Operating Margin is Increasing

-471% > -378%

Negative Net Margin

-372%

Negative 3Y Average Net Margin

-374%

Net Margin is Increasing

-461% > -372%

Negative Free Cash Flow Margin

-408%

Negative 3Y Average Free Cash Flow Margin

-409%

Free Cash Flow Margin is Increasing

-515% > -408%

Negative ROE

-92%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-127%

ROIC is Increasing

-154% > -153%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.